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Abstract
Autophagy is a cellular self-digestion process activated in response to stresses such as energy deprivation and oxidative
stress. However, the mechanisms by which energy deprivation and oxidative stress trigger autophagy remain undefined.
Here, we report that activation of AMP-activated protein kinase (AMPK) by mitochondria-derived reactive oxygen species
(ROS) is required for autophagy in cultured endothelial cells. AMPK activity, ROS levels, and the markers of autophagy were
monitored in confluent bovine aortic endothelial cells (BAEC) treated with the glycolysis blocker 2-deoxy-D-glucose (2-DG).
Treatment of BAEC with 2-DG (5 mM) for 24 hours or with low concentrations of H2O2 (100 mM) induced autophagy,
including increased conversion of microtubule-associated protein light chain 3 (LC3)-I to LC3-II, accumulation of GFP-tagged
LC3 positive intracellular vacuoles, and increased fusion of autophagosomes with lysosomes. 2-DG-treatment also induced
AMPK phosphorylation, which was blocked by either co-administration of two potent anti-oxidants (Tempol and N-Acetyl-L-
cysteine) or overexpression of superoxide dismutase 1 or catalase in BAEC. Further, 2-DG-induced autophagy in BAEC was
blocked by overexpressing catalase or siRNA-mediated knockdown of AMPK. Finally, pretreatment of BAEC with 2-DG
increased endothelial cell viability after exposure to hypoxic stress. Thus, AMPK is required for ROS-triggered autophagy in
endothelial cells, which increases endothelial cell survival in response to cell stress.
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Introduction
Autophagy is a tightly regulated catabolic process involving the
degradation of cellular components using lysosomal machinery.
This process plays an important role in cell growth, development,
and homeostasis by maintaining a balance between the synthesis,
degradation, and subsequent recycling of cellular products.
Autophagy is a major mechanism by which a starving or stressed
cell reallocates nutrients from ancillary processes to more essential
ones [1–2]. For example, autophagy can be induced by hypoxia
[3], energy deprivation [4], starvation [5] and ischemia [6].
Mechanistically, autophagy is initiated when the autophagosome,
a double-membrane structure, is formed to surround certain
targeted cytoplasmic proteins and organelles. This process and the
double-membrane structures are associated with the conversion of
the microtubule-associated protein light chain 3B-I (LC3-I) to
LC3B-II. The protein/organelle containing autophagosome
fuses with a lysosome to degrade its inner contents [1]. Lyso-
somes can be disrupted by chloroquine or bafilomycin A to
block autophagosome degradation and provoke autophagosome
accumulation, which is marked by an increase in LC3-II [7].
Increasing evidence suggests that autophagy plays an important
role in the cardiovascular system under physiological and
pathological conditions including ischemia-reperfusion injury in
the heart and other organs [8], cardiomyopathy [9], myocardial
injury, atherosclerosis [10,11], and vascular pathology in Alzhei-
mer’s disease [12].
Reactive oxygen species (ROS) and reactive nitrogen species
(RNS) are reported to be important in mediating autophagy
[13,14]. ROS have also been reported to stabilize autophagosomes
during periods of nutrient deprivation, hypoxia, ischemia-
reperfusion injury, and general cell stress [15]. For example,
during cellular starvation or nutrient deprivation, increased
generation of mitochondrial-derived hydrogen peroxide (H2O2)
induces oxidation and consequent inhibition of Atg4, the cysteine
proteases (autophagins) which play crucial roles in autophagy by
proteolytic activation of Atg8 paralogs for targeting to autophagic
vesicles by lipid conjugation, as well as in subsequent deconjuga-
tion reactions [16]. Despite of growing evidence that the redox
regulation of the cysteine protease Atg4 by ROS correlates with
the occurrence of autophagy, the mechanistic details of how
ROS/RNS initiates autophagy remain to be elucidated.
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switch that is engaged in conditions when cellular ATP is becoming
depleted. Upon activation, AMPK induces formation of the tuberous
sclerosiscomplex to inhibit phosphorylation of the mammalian target
of rapamycin (mTOR), which triggers autophagy through two
downstream signaling partners, ribosomal protein S6 kinase and 4E-
binding protein 1(4-eBP1) [17]. Some recent reports have implicated
AMPK with regulation of autophagy. For example, aminoimidazole
carboxamide ribonucleotide (AICAR) treatment and glucose depri-
vation of human mammary cancer derived cells (MCF-7s) inhibit
autophagy [18]. Matsui and colleagues also reported that in cardiac
myocytes, autophagy is induced by inhibition of mTOR, a
phenomenon that protects against cell death [19].
Published studies from our laboratory and others have
established an intricate balance between AMPK signaling and
the redox state of vascular endothelial cells. ROS and RNS
mediate AMPK activation induced by a wide range of stimuli,
including hyperglycemia [20], hypoxia [21], treatment with
metformin [22], nicotine [23], and therapy with statin drugs
[24]. Conversely, AMPK activation inhibits the formation of ROS
by NADPH oxidase and stimulates nitric oxide (NO) by
endothelial NO synthase (eNOS) [25]. Further, AMPK has also
been implicated in c-Jun N-terminal kinase (JNK) activation,
nuclear factor (NF)- kB mediated transcription, E-selectin and
vascular cell adhesion molecule-1 (VCAM-1) expression in
endothelial cells [26]. However, whether or not AMPK is involved
in ROS-triggered autophagy is unknown.
2-Deoxy-D-glucose (2-DG) is a relatively specific blocker for
glycolysis because it cannot be further metabolized by hexokinase.
Therefore, 2-DG triggers glucose deprivation without altering other
nutrients or metabolic pathways [27]. In addition, 2-DG is reported
to activate AMPK, increase ROS in cancer cells [28], and trigger
autophagy [29]. Thus, 2-DG appears to be an ideal tool to dissect
the interactions between autophagy, ROS, and AMPK. However,
while 2-DG induces autophagy in cancer cells and mouse
embryonic fibroblasts [30,31], its ability to trigger autophagy in
endothelial cells has not been demonstrated. In this study, we
provide the first demonstration that AMPK is required for ROS-
triggered autophagy in endothelial cells exposed to 2-DG.
Materials and Methods
Materials
Bovine aortic endothelial cells (BAEC) were obtained from
Lonza Biologics, Inc. (Walkersville, MD). Human umbilical vein
endothelial cells (HUVEC) were purchased from Cascade
Biologics (Portland, OR). [c-
32P] was purchased from PerkinElmer
Life Sciences (Waltham, MA). 2-DG, 4-hydroxy-Tempo, N-
Acetyl-L-cysteine (NAc), ATP, ADP, AMP, allopurinol, and
oxypurinol were purchased from Sigma-Aldrich (St. Louis, MO).
Protein A/G-agarose, AMPKa siRNA, and UCP-2 siRNA were
obtained from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA). 5
(and-6)-chloromethyl-29,79-dichlorofluorescein diacetate, acetyl
ester (CM-H2DCFDA), and Lipofectamine 2000 reagent were
obtained from Invitrogen Corp. (Carlsbad, CA). Antibodies
against phospho-acetyl-CoA carboxygenase (ACC; Ser79), phos-
pho-AMPK (Thr172), phosphor-mTOR (Ser2448), AMPK,
LC3B, and b-actin were purchased from Cell signaling Technol-
ogy, Inc. (Beverly, MA). Antibody against UCP-2 was obtained
from Santa Cruz Biotechnology, Inc.
Cell Culture
BAEC and HUVEC were grown in endothelial cell basal
medium (EBM) containing fetal bovine serum (5%, v/v), growth
factors (Lonza) and 1% antibiotics (Invitrogen). BAEC and
HUVEC were both cultured at 37uC in a 5% CO2 humidified
atmosphere. Confluent BAEC and HUVEC were studied between
passages 3 and 9.
Adenoviral Infection
Proliferating BAEC at 60% confluence in a 6-well plate
were inflected with adenovirus encoding super oxide dismutase 1
(SOD1), catalase, MnSOD, AMPK-dominant negative mutants
(AMPK-DN), p47
phox-domitant negative mutants (p47-DN), or
p67
phox -dominant negative mutants (p67-DN). Adenovirus expres-
sion of green fluorescence protein (GFP) was used as negative
control. After 48 hrs, the infection efficiency exceeded 80% as
determined by the number of GFP-expressing cells.
siRNA Transfection
Control non-targeted siRNA, AMPKa, or UCP-2 targeted
siRNA (10 mM) were added to OPTI-MEM reduced serum media
(GIBCO, Invitrogen) with Lipofectamine
TM 2000. Proliferating
HUVEC at 60% confluence in a 6-well plate were incubated in
1.0 mL EBM supplemented with siRNA for 6 hrs. Then 1.0 mL
EBM containing 2X fetal bovine serum and antibiotics was added,
and the cells cultured for 24 hrs.
Determination of ROS
BAEC were incubated in EBM without phenol red containing
CM-H2DCFDA (5 mM) as a membrane-permeable probe to
detect intracellular ROS, under various stimulation conditions.
After 30 min incubation, fluorescence was detected using a
Synergy HT microplate reader (BIO-TEK) with excitation set at
490 nm and emission detected at 520 nm.
Measurement of AMP, ADP, and ATP
AMP, ADP, and ATP in BAEC were assessed by high
performance liquid chromatography (HPLC) as described
previously [32].
AMPK Activity Assay
AMPK activity was determined using the SAMS peptide as an
AMPK substrate, as previously described [22].
Western Blotting and Quantification
Western blot was performed as described previously [22]. Band
intensity (area 6 density) on Western blots was analyzed by
densitometry (model GS-700, Imaging Densitometer; Bio-Rad,
Hercules, CA). Background was subtracted from the quantification
area.
Light Microscopy and Immunofluorescence
Confluent BAEC on glass slides were transduced with LC3B-
GFP encoding BacMam virus (Invitrogen) for 24 hrs. BAEC were
then incubated for 0.5 hr with 1 mM LysoTracker Red (Invitro-
gen) and rinsed several times with PBS. The cells on the slides
were fixed with 4% formaldehyde for 10 min and permeablized
with 0.2% triton X-100 for 20 min. The slides were mounted and
observed with OLYMPUS IX71 microscope (Olympus, Tokyo,
Japan).
Statistical Analysis
Data are presented as mean 6 standard error of the mean
(SEM). Differences were analyzed by using a one-way analysis
of variance (ANOVA) followed by a Tukey post-hoc analysis.
p values less than 0.05 were considered statistically significant.
Autophagy in Endothelial Cells
PLoS ONE | www.plosone.org 2 February 2011 | Volume 6 | Issue 2 | e17234Results
2-DG induces autophagy in endothelial cells
To establish whether 2-DG exposure triggered autophagy in
endothelial cells, BAEC were exposed for 2 to 24 hrs to 5 mM
2-DG, a dose comparable to the physiologic concentration of
D-Glucose, and the conversion of LC3-I to LC3-II was then
determined. Exposure of BAEC to 2-DG for 24 hrs markedly
increased the conversion of the cytoplasmic LC3-I to the
autophagosomal membrane-bound LC3-II, indicating 2-DG
might induce autophagy (Fig. 1A). However, rather than inducing
autophagy, an increase in LC3-II could instead be due to 2-DG
repressing autophagosome fusion with lysosomes and degradation
of LC3-II. To determine the mechanism of 2-DG action, we
examined the effect of disrupting lysosomal function using
chloroquine and bafilomycin A. These compounds increase
lysosomal pH and interfere with the function of lysosomal
enzymes [7], thereby increasing autophagosome accumulation in
the cell. BAECs treated with 2-DG and chloroquine or
bafilomycin A had higher levels of LC3-II than cells treated with
2-DG alone (Fig. 1B), which indicates 2-DG acts by inducing
autophagosome formation and does not disrupt their downstream
maturation into autophagolysosomes.
To confirm the effect of 2-DG on autophagosome formation,
immunofluorescence analysis of BAEC expressing GFP-LC3 and
stained with Lysotracker (an organelle-selective, fluorescent probe
that labels and tracks acidic organelles, such as lysosomes) was
preformed. 2-DG increased formation of autophagosomes,
indicated by increase in the number and distribution of GFP-
tagged LC3 spots (Fig. 1C). Treatment of cell with both 2-DG and
chloroquine further increased the number and distribution of
LC3-GFP spots in these cells. Further, 2-DG increased fusion of
GFP-LC3 tagged vacuoles with lysosomes, which is indicated by
co-localization of GFP-LC3 with LysoTracker stained vesicles
(Fig. 1C, merged image). This demonstrated that 2-DG treatment
increased fusion of autophagosomes with lysosomes, a definitive
event in the induction of cellular autophagy. Together, these data
show that 2-DG induces conversion of LC3-I to LC3-II and
triggers autophagy in endothelial cells.
H2O2 mediates 2-DG-induced autophagy
Current literature indicates that H2O2 induces autophagy in
HeLa cells and HEK293 cells [14,33]. These findings are
intriguing because nutrient starvation (such as 2-DG treatment)
is known to generate ROS in a variety of cell types. We therefore
tested whether H2O2 could also trigger autophagy in endothelial
cells. Treatment of BAEC for 30 min with H2O2 (100 mM)
increased the LC3-II-to-actin ratio 1.6-fold (Fig. 1D). We also
reasoned that blocking the effects of ROS should mitigate the
phenotype of 2-DG-induced autophagy. We tested this hypothesis
by assessing the effect of 2-DG on the conversion of LC3I to
LC3II in BAEC overexpressing either SOD1 or catalase from an
adenovirus vector. SOD1 is an enzyme that buffers O2
2 by
converting it to H2O2 and catalase then scavenges H2O2 (Figure
S1 in Text S1). Both SOD1 and catalase overexpression decreased
2-DG-enhanced LC3-II conversion. 2-DG treatment of cells
expressing the GFP negative control had a 2.0-fold increase in
LC3-II conversion, which was higher than the 1.5-fold increase
observed in SOD1-overexpressing cells and 1.4-fold increase in
catalase-overexpressing cells (Fig. 1E). To further elucidate the
effect of antioxidant enzyme overexpression on 2-DG-induced
autophagosome formation, immunofluorescence analysis of BAEC
expressing GFP-LC3 was preformed. 2-DG treatment (lower three
panels) increased formation of autophagosomes (green fluorescent
spots) compared to non-2-DG treated cells (Fig. 1F). However,
SOD1 and catalase overexpression attenuated the 2-DG-mediated
formation of autophagosomes. Overall these results indicate that
ROS are critically involved in 2-DG-induced autophagy and that
H2O2 treatment of endothelial cells induces autophagy.
2-DG induced AMPK activation in a dose- and time-
dependent manner
To further establish if ROS is responsible for 2-DG-induced
AMPK activation, we performed a time-course study to determine
if ROS production proceeds AMPK activation. Confluent BAEC
were stimulated with 5 mM 2-DG for 5 to 120 min, and AMPK
activation was measured by monitoring phosphorylation of
AMPKa-Thr172. As depicted in Fig. 2A, 2-DG treatment
increased the phosphorylation of AMPKa-Thr172 within 5 min,
and this reached a maximum of 2.8-fold greater than that in 2-DG
untreated cells by 10 min after treatment without affecting the
total AMPK levels. After 10 min, phosphorylated AMPKa-
Thr172 levels decreased and returned to basal levels by 60 min
after treatment. ACC is a well-established downstream target of
AMPK and is activated by phosphorylation of Ser79. We
measured ACC-Ser79 phosphorylation and observed a similar
time course for ACC activation as that for AMPK (Figure S1 in
Text S1). Further, 2-DG increased the phosphorylation of AMPK-
Thr172 (Fig. 2B) and ACC-Ser 79 (Figure S1 in Text S1) in a
dose-dependent manner. 2-DG also increased AMPK activity to
4-fold after 5 min compared to basal activity and reached a peak
5.5-fold higher than basal activity after 10 min (Fig. 2C). These
data establish that 2-DG induces AMPK activation in both a time-
and dose-dependent manner.
AMPK is required for 2-DG-induced autophagy
In cancer cells, AMPK is reported to be a key regulator of
autophagy via a mechanism that involves inactivation of mTOR
[30] and cardiac myocytes [31]. We therefore explored whether
AMPK was also involved in 2-DG-induced autophagy in
endothelial cells. BAEC were transduced with an adenovirus
vector encoding a dominant-negative AMPK (AMPK-DN) to
block cellular AMPK functions. 2-DG treatment of cells expressing
the GFP negative control for 24 hrs induced a 2-fold increase in
LC3-II levels, but AMPK-DN overexpression blocked the 2-DG-
induced increase in LC3-II levels (Fig. 3A). We confirmed these
results by siRNA-mediated silencing of the AMPKa gene, which is
the critical catalytic subunit of AMPK in HUVEC (Fig. 3B). As
observed in BAEC, 2-DG treatment increased LC3-II levels 2-fold
by 24 hrs post treatment in cells transfected with non-targeted
control siRNA, but transfection with AMPKa1/2-targeted siRNA
dramatically inhibited AMPK expression and reduced the 2-DG-
induced increase in the LC3-II levels to 1.3-fold (Fig. 3B). Taken
together, these data show that AMPK is required for 2-DG-
induced autophagy in endothelial cells.
AMPK induces autophagy via downstream mTOR
signaling
The mTOR integrates the input from several upstream
pathways by sensing the nutrient levels, bioenergetic status, and
redox state of the cell [34]. We hypothesized that mTOR signaling
was involved in the 2-DG induced AMPK-mediated induction of
autophagy. We therefore examined phosphorylation status of
AMPK and mTOR after AICAR, 2-DG, and rapamycin
treatment. The 70-kDa ribosomal protein S6 kinase (p70S6K)
and eukaryote initiation factor 4E binding protein 1 (4E-BP1) are
the two well-characterized targets of mTORC. When we probed
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PLoS ONE | www.plosone.org 3 February 2011 | Volume 6 | Issue 2 | e17234Figure 1. 2-DG-induced autophagy is ROS-dependent. A: Confluent monolayers of BAEC were treated with 5 mM 2-DG for the indicated times.
Cell lysates were analyzed by Western blot using antibody against LC3B. (n=3; one-way ANOVA: *p,0.05 vs control). B: Confluent monolayers of
BAEC were treated with 5 mM 2-DG for 24 hrs in the presence or absence of chloroquine (3 mM) or bafilomycin A (10 nM). Cell lysates were analyzed
by Western blot for detection of LC3. (n=3; two-way ANOVA: *p,0.05 2-DG vs vehicle, 2-DG + chloroquine vs. chloroquine, 2-DG + bafilomycin A vs.
bafilomycin A. p,0.05, 2-DG vs. 2-DG + bafilomycin A or 2-DG + chloroquine). C: BAEC expressing GFP-LC3 were treated with chloroquine or 2-DG,
and the accumulation of LC3 II (green), localization of LC3 II with lysosomes (red), and DAPI (blue) staining of nuclei in response to treatment were
analyzed by fluorescence microscopy. Scale bars, 5 mm. D: Confluent monolayers of BAEC were treated with 100 mMH 2O2 for the indicated times. Cell
lysates analyzed by Western blot using antibody against LC3 (n=3; one-way ANOVA: *p,0.05 vs control). E: BAEC were transduced adenovirus
vectors encoding SOD1 or catalase for 48 hrs and then exposed to 5 mM 2-DG for 24 hrs (n=3; two-way ANOVA, * p,0.05, GFP vs. 2-DG, SOD1 vs
Autophagy in Endothelial Cells
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and 2-DG led to the phosphorylation of AMPK as well as its
upstream activator ACC (Fig. 2C). As predicted, both AICAR and
2-DG also attenuated the phosphorylation of mTOR and its two
targets, p706K and 4E-BP1. Similarly, the canonical mTOR
inhibitor rapamycin increased of LC3-II levels without affecting
AMPK phosphorylation (Fig. 2C and Figure S2 in Text S1). Thus,
we concluded that 2-DG induced autophagy via activation of
AMPK, which functions through the downstream inhibition of the
mTOR signaling pathway.
ROS is involved in 2-DG-induced AMPK activation, which
can be attenuated by anti-oxidant treatment
Recent studies using cancer cell lines [28] and C. Elegans [35]
showed that glucose deprivation activated AMPK by production
of ROS. However, it is not clear whether ROS also regulate 2-
DG-induced AMPK activation in endothelial cells. To evaluate
this, we first examined the effects of antioxidants on 2-DG-induced
AMPK activation in BAEC. Pre-treatment of BAEC with Tempol
(an O2
2 scavenger; 10 mM) or NAc (a thiol antioxidant; 2 mM)
significantly reduced 2-DG-enhanced phosphorylation of AMPK.
In addition, NAc inhibited ACC phosphorylation induced by
2-DG (Fig. 4A and B, Figure S2 in Text S1). We further assayed
AMPK activity in BAEC by quantifying phosphorylation of the
SAMS peptide, an AMPK substrate, using a [
32P]-ATP assay.
After treatment with 2-DG (5 mM), AMPK activity was 3-fold
greater than baseline within 10 min, and NAc treatment caused
AMPK activity to drop from 3-fold to 2-fold over baseline levels
(Fig. 4C). Finally, we overexpressed antioxident proteins SOD1 or
catalase to further examine the involvement of ROS (Figure S3 in
Text S1). Overexpression of either SOD1 or catalase, but not
GFP, attenuated 2-DG-enhanced phosphorylation of AMPK and
ACC (Fig. 4D). In the SAMS peptide phosphorylation assay,
2-DG treatment increased AMPK activity 7-fold, and this was
enhanced 2-fold by overexpression of SOD1 and 2.5-fold by
overexpression of catalase (Fig. 4E). Overall these results indicate
that ROS are involved in 2-DG-induced AMPK activation in
endothelial cells, a phenomenon that is reversible if ROS levels are
suppressed with anti-oxidants.
2-DG increases intracellular H2O2 levels in endothelial
cells
We next determined the effect of 2-DG on ROS production in
endothelial cells using CM-H2DCFDA as an intracellular H2O2
probe. It is known that AMPK activation by AICAR reduces the
generation of ROS [20]. To circumvent the confounding potential
of ROS attenuation by AMPK activation, we detected intracel-
lular H2O2 in 2-DG-stimulated HUVEC transfected with AMPK-
targeted siRNA. As expected, the intracellular H2O2 levels in cells
in which AMPKa1/2 was knocked down were significantly higher
than in cells transfected with the non-targeted control siRNA
following a 10–min, 5-mM 2-DG treatment (Fig. 5A). Pre-
treatment with a catalase inhibitor 3-amino-1,2,4-triazine (ATZ)
and thioredoxin reductase inhibitor 1-chlo-2,4-dinitrobenzene
Figure 2. Time-course and dose-response for 2-DG-induced AMPK activation. A: Confluent BAEC monolayers were treated with 2-DG
(5 mM) for the indicated times. Cell lysates were analyzed by Western blot using antibody against p-AMPK and AMPKa1/2 (n=3; one-way ANOVA:
*p,0.05 vs. control). B: Confluent BAEC monolayers were treated with the indicated concentration of 2-DG for 10 min (n=3; one-way ANOVA:
*p,0.05 vs. control). C: BAEC were incubated with 5 mM of 2-DG for the indicated times. AMPK was immunoprecipitated from cell lysis with an
antibody against AMPKa bound to Protein A/G agarose overnight at 4uC. AMPK activity was determined by SAMS phosphorylation using a [
32P]ATP
assay (n=3; one-way ANOVA, *p,0.05 vs. control).
doi:10.1371/journal.pone.0017234.g002
2-DG + SOD1, catalase vs 2-DG + catalase, p,0.05, 2-DG vs. 2-DG + catalase overexpression). F: The accumulation of LC3 II (green), localization of LC3
II lysosomes (red), and DAPI (blue) staining of nuclei in response to SOD1 or catalase overexpression and 2-DG treatment were analyzed by
fluorescence microscopy.
doi:10.1371/journal.pone.0017234.g001
Autophagy in Endothelial Cells
PLoS ONE | www.plosone.org 5 February 2011 | Volume 6 | Issue 2 | e17234Figure 3. 2-DG-induced autophagy is AMPK-dependent. A: BAEC were transduced with adenovirus vectors encoding dominant negative
AMPK (AMPK-DN) for 48 hrs and then treated with 5 mM 2-DG for 24 hrs (n=3; two-way ANOVA, * p,0.05, GFP vs. 2-DG, p,0.05, 2-DG vs. 2-DG
+ AMPK-DN). B: HUVEC were transfected with AMPK-targeted siRNA or control siRNA for 24 hrs then treated with 5 mM 2-DG for 24 hrs. Cell lysates
were analyzed by Western blot using antibody against LC3 (n=3; two-way ANOVA, * p,0.05, vehicle vs. 2-DG, p,0.05, Control siRNA vs. AMPK
siRNA). C: BAEC were treated with 1 mM AICAR, 10 nM rapamycin, or 5 mM 2-DG for 24 hrs and then analyzed by Western blot to determine the level
of phospho-AMPK-Thr172 (p-AMPK), phos-ACC-Ser79 (p-ACC), phos-mTOR-Ser2448 (p-mTOR), mTOR, phos-p70S6K-Thr389 (p-p70S6K), p70S6K, phos-
4EBP1-Thr37/46 (p-4EBP1), and LC3.
doi:10.1371/journal.pone.0017234.g003
Figure 4. Inhibitory effects of antioxidants on 2-DG-induced AMPK activation in BAEC. A, B: Confluent BAEC monolayers were pretreated
with 10 mM 4-hydroxy-Tempol (Tempol) or 2 mM N-Acetyl-Cysteine (NAc) for 30 min and then treated with 5 mM 2-DG for 10 min. Cell lysates were
subjected to Western blot analysis using antibodies against p-AMPK, p-ACC, AMPKa1/2, and b-actin (n=3; two-way ANOVA,* p,0.05, 2-DG vs. control,
Tempol + 2-DG vs. Tempol, NAc + 2-DG vs. Nac, p,0.05 2-DG vs 2-DG + Tem or NAc). C: BAEC were pretreated with NAc and then stimulated with 2-DG.
AMPK activity was determined by SAMS phosphorylation using a [
32P]ATP assay (n=3; two-way ANOVA, * p,0.05, vehicle vs 2-DG, Nac vs 2-DG +
NAc, p,0.05 2-DGvs. 2-DG + NAc). D,E:ConfluentBAEC monolayers weretransduced withadenovirus vectorsencodingSOD1 orcatalasefor48 hrs and
then treated with 5 mM 2-DG for 10 min. Phosphorylation of AMPK and AMPK activity were detected, as described in the Matierals and Methods (n=3;
two-way ANOVA, * p,0.05, GFP vs. 2-DG, SOD1 vs 2-DG + SOD1, catalase vs 2-DG + catalase, p,0.05, 2-DG vs. 2-DG + SOD1 or catalase overexpression).
doi:10.1371/journal.pone.0017234.g004
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2-DG-treated BAEC (Fig. 5B and C).
Suppression of Atg4 attenuates 2-DG induced autophagy
Sherz-Shouval et al. [16] recently reported that ROS are
essential for autophagy and specifically regulate the activity of
Atg4. Although these studies were done in Chinese Hamster
Ovary and HeLa cell lines, it is likely that these results can be
extrapolated to endothelial cells as well. Based on these findings,
we examined Atg4 expression in HUVEC after 2-DG treatment or
after transfection of Atg4-targeted siRNA. As shown in Fig. 5D,
silencing of Atg4 efficiently blocked Atg4 expression in HUVEC.
Further, 2-DG treatment of Atg4-silenced cells led to an
attenuated increase in LC3-II levels. These findings are consistent
with the observation that H2O2 inhibits Atg4, which in turn
promotes lipidation of Atg8 leading to increased autophagy.
ROS-dependent AMPK activation is independent of
changes in the AMP-to-ATP ratio
Scott et al. found that there are regulatory AMP- and ATP-
binding sites in the subunits of AMPK [36]. As a consequence,
high concentrations of ATP antagonize AMPK activation that
results from AMP binding to the heterotrimer. 2-DG appears to
induce AMPK activation primarily through the decrease in
intracellular ATP levels that results from blocking glycolysis. We
speculated that ROS-mediated AMPK activation via glucose
deprivation might not depend on a change in the AMP-to-ATP
ratio. We therefore quantified the ADP:ATP and AMP:ATP ratios
in BAEC exposed to 2-DG at different time points after treatment.
Both AMP:ATP and ADP:ATP ratios significantly increased by
5 min after 2-DG addition (Fig. 6A). Neither pretreatment of
BAEC with Tempol or NAc (Fig. 6B) nor overexpression of SOD1
or catalase inhibited the observed increase in these ratios (Fig. 6C).
This is the first study to demonstrate that 2-DG-induced AMPK
activation is mediated by ROS and is likely independent of the
AMP:ATP nucleotide ratio.
Mitochondria are the sources of ROS in 2-DG-treated
endothelial cells
Mitochondria, NAD(P)H oxidase, and xanthine oxidase [37]
can generate ROS in both physiological and pathological
conditions. We sought to identify the major sources of ROS
synthesis in 2-DG-treated endothelial cells. Mito-Tempol is a
synthetic Tempol derivate that preferentially scavenges O2
2 from
mitochondria. Pre-treatment of cells with 10 mM mito-Tempol for
30 min dramatically decreased 2-DG-induced phosphorylation of
AMPK (Fig. 7A). Further, overexpression of MnSOD, a SOD
isoform located in the mitochondrial matrix (Figure S3 in Text
S1), attenuated the 2-DG-induced phosphorylation of AMPK and
ACC (Fig. 7B).
Mitochondrial uncoupling protein-2 (UCP-2) is a mitochondrial
anion carrier protein that mediates mitochondrial proton leakage
and uncouples ATP synthesis from oxidative phosphorylation.
UCP-2 overexpression (Figure S3 in Text S1) dramatically
decreased the 2-DG phosphorylation of AMPK and ACC
(Fig. 6C). Consistently, transfection of UCP-2-targeted siRNA,
Figure 5. 2-DG increases intracellular synthesis of H2O2 to induce autophagy. A: HUVEC were transfected with AMPK-targeted siRNA for
24 hrs. Then the cells were incubated in EBM media without phenol red and treated with 5 mM of 2-DG for 10 min. CM-H2DCFDA (10 mM; Invitrogen)
was added for 30 min before quantification of fluorescence (excitation at 485 nm and emission at 545 nm). (n=3; two-way ANOVA,* p,0.05, 2-DG vs.
vehicle). B: BAEC were pre-treated with 3-amino-1,2,3-triazine (ATZ, 100 mM) and 1-chloro-2,4-dinitrobenzene (DNCB, 100 mM) for 30 min and then
treated with 2-DG for 5 or 10 min. Intracellular H2O2 levels were detected by fluorescence using CM-H2DCFDA. (n=3; two-way ANOVA,* p,0.05, ATZ
+ DNCB vs. vehicle, p,0.05, 2-DG + ATZ + DNCB vs. ATZ + DNCB). C: BAEC were treated with 2-DG for 24 hrs. Intracellular H2O2 levels were detected
by fluorescence using CM-H2DCFDA. (n=3; t-test,* p,0.05, 2-DG vs. vehicle). D,E: HUVEC were transfected with Atg4-targeted siRNA or control siRNA
for 24 hrs and then treated with 5 mM 2-DG for 24 hrs. Cell lysates were analyzed by Western blot using antibody against LC3 (n=3; two-way
ANOVA, * p,0.05, vehicle vs. 2-DG, p,0.05, Control siRNA vs. Atg4 siRNA).
doi:10.1371/journal.pone.0017234.g005
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levels and 2-DG-induced AMPK phosphorylation in HUVEC
(Fig. 7D and Figure S3 in Text S1). To further identify the sources
of ROS in these cells, we used infected cells with adenovirus
vectors carrying dominant negative subunits of NADPH oxidase to
induce NAD(P)H oxidase dysfunction. p47
phox and p67
phox are
subunits of the NADPH oxidase that activate NAD(P)H oxidase
activity by binding with gp91
phox on the mitochondrial membrane
[38], but expression of dominant negative p47
phox (p47-DN) and
p67
phox (p67-DN) lead to NAD(P)H oxidase dysfunction. p47-DN
or p67-DN overexpression did not affect 2-DG-induced AMPK
and ACC phosphorylation (Fig. 7E and Figure S3 in Text S1).
Moreover, incubation of BAEC with the xanthine oxidase
inhibitors, allopurinol and oxypurinol, did not block 2-DG-
induced AMPK and ACC phosphorylation (Fig. 7F and G).
These findings strongly suggest that mitochondria are the main
source of ROS induced by 2-DG in BAEC.
AMPK-regulated autophagy contributes to endothelial
cell survival under hypoxic conditions
We next sought to demonstrate the physiological relevance of our
findings. For this purpose, we exposed BAEC to hypoxic conditions
and treated them with 2-DG to determine the role that autophagy
plays under hypoxic conditions. As showed in Figure 8A, we
observed increased cell death in BAEC after 12 hrs of hypoxia.
Interestingly, 2-DG pre-treatment prevented the hypoxia-induced
cell death. We quantified the release of lactate dehydrogenase
(LDH) from cells as a marker of plasma membrane damage,
reflecting the degree of cell death. LDH release, and therefore cell
death, in BAEC pre-treated with 2-DG (5 mM) was significantly
lower than that in untreated cells (Fig. 8A). In these experiments, we
were also able to demonstrate that whereas 2-DG protected cells
from hypoxia-induced death, pre-treatment with 3-methyladenine
(3-MA), an autophagy inhibitor, partially blocked the 2-DG-
induced protection (Fig. 8B). In contrast, SOD1 or catalase
overexpression blocked the 2-DG-induced protection and cell
survival under hypoxic conditions (Fig. 8C). Finally, AMPK-DN
overexpression prevented 2-DG-induced cell survival (Fig. 8D).
Together, these results show that 2-DG induces autophagy through
AMPK activation in a ROS-dependent manner, thereby protecting
cells from hypoxia-induced cell death.
Discussion
The present study has, for the first time, demonstrated that
AMPK activation by mitochondrial ROS is required for the
induction of autophagy in endothelial cells. Mechanistically, we
found that ROS, via AMPK activation, increase autophagy by
inhibition of mTOR and Atg4 activity and ROS-triggered
autophagy increases endothelial cell survival under hypoxic
conditions. Thus, our results reveal a novel signaling pathway in
which mitochondrial ROS activate AMPK that in turn increases
autophagy. Induction of autophagy then serves to increase
endothelial cell survival (Fig. 8E).
Figure 6. Inhibition of AMPK by antioxidants is independent of the AMP:ATP ratio. A: Confluent BAEC monolayers were treated with
5 mM of 2-DG for the indicated times. Cells were lysed by perchloric acid and centrifuged as described in the Materials and Methods. The ultrafiltrate
was injected into a Jasco HPLC, and ATP, ADP, and AMP were monitored at 260 nm. (n=4; one-way ANOVA, * p,0.05, ** p,0.01, Control vs. 2-DG
treatment). B: BAEC monolayers were pre-treated with 10 mM Tempol or 2 mM NAC and then treated with 5 mM of 2-DG for 5 min. The AMP:
ATP ratio in cell lysates was measured by HPLC (n=5; two-way ANOVA,* p,0.05, ** p,0.01, 2-DG vs. vehicle, Tempol vs. 2-DG + Tempol, NAc vs. 2-DG
+ NAc). C: BAEC overexpressing SOD1 or catalase were treated with 5 mM 2-DG for 5 min. The AMP:ATP ratio in cell lysates was measured by HPLC.
(n=3;*p,0.05, ** p,0.01, two-way ANOVA, GFP vs. 2-DG, SOD1 vs. 2-DG + SOD1, catalase vs. 2-DG + catalase).
doi:10.1371/journal.pone.0017234.g006
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which consequently elevates the AMP:ATP ratio and activates
AMPK [29]. Recent study has demonstrated that glucosedeprivation
increases O2
2 and H2O2 generation in human colon and breast
cancer cells [40]. Our results demonstrate that 2-DG induces
autophagy in endothelial cells, a phenomenon not previously
reported in this cell type. Specifically, we have shown that whether
AMPK is activated via nutritional stress (as in exposure to 2-DG) or
by induction of ROS synthesis, endothelial cells activate an
autophagy signaling pathway rather than a cell death pathway. This
result is consistent with other published data. For example, Matsuda
et al. reported that 2-DG induces autophagy in A/J mouse peritoneal
macrophages [41]. This process is also likely to be involved in the
ability of 2-DG to prevent brain injury induced by ischemia-
reperfusion [42]. 2-DG is also reported to decrease phosphorylation
of mTOR and its downstream targets, p70S6k and 4E-BP1, in
human breast cancer cells, leading to a reduced carcinogenic
response and attenuated tumorigenicity [43]. AMPK activation also
represses mTOR activity in cells with reduced energy stores or after
AICAR treatment [44]. Consistent with these findings, our results
demonstrate that 2-DG induces autophagy through an AMPK-
regulated pathway, and siRNA-mediated AMPK knockdown
prevents conversion of LC3-I to LC3-II. Most compelling of all, in
our validation of data showing the involvement of H2O2 in 2-DG-
enhanced phosphorylation of AMPK, we were also able to
demonstrate that ROS are involved in the coordinated role of 2-
DG and AMPK on autophagy. Overall, these data indicate a novel
autophagy signaling pathway important for endothelial cell survival.
Our results have further demonstrated that ROS might be a
general mechanism for AMPK activation under certain physio-
logical conditions, including glucose deprivation. Consistent with
these findings, Cai et al. demonstrated that glucose deprivation
induces ROS production to activate AMPK in pancreatic b cells
[45]. Several groups, including our own, have previously shown
that diverse stimuli can induce ROS generation, and in general,
this results in AMPK activation. Exposure to different oxygen
concentrations, ranging from frank hypoxia [46] to hyperemia
[47], triggers AMPK activation via mitochondrial ROS produc-
tion. In addition, many exogenous stimuli, such as free fatty acids,
including palmitic acid and arachidonic acid [48], pharmacolog-
ical stimuli, such as metformin [22], etoposide, and resveratrol
have all been observed to increase AMPK activation through a
mitochondrial ROS mechanism. All of these compounds are
potentially important drug treatments. Metformin is a common
treatment for diabetes and metabolic syndrome. Etoposide is a
cancer therapeutic agent that inhibits topoisomerase II activity,
and resveratrol is a botanical phytoallexin that has shown
beneficial effects on hyperglycemia in animal models of diabetes
[49]. Phosphorylation of AMPK via ROS is also seen to occur in
skeletal muscle during both stretch [50] and contraction [51].
Figure 7. Activation of AMPK by 2-DG is mediated by mitochondrial ROS independent of NAD(P)H oxidase and xanthine oxidase.
A: Confluent BAEC monolayers were pre-treated with 10 mM mito-Tempol for 30 min and then treated with 5 mM of 2-DG for 10 min. Cell lysates
were analyzed by Western blot using antibody against p-AMPK (n=3; two-way ANOVA, *p,0.05, vehicle vs 2-DG, p,0.05, 2-DG vs. 2-DG + mito-Tem).
B, C, E: Confluent BAEC monolayers were transduced with adenovirus vectors encoding MnSOD (B), UCP2 (C), or p47
phox and p67
phox dominant
negative mutants (E) for 48 hrs and then treated with 5 mM 2-DG for 10 min. (n=3; two-way ANOVA, * p,0.05, GFP vs 2-DG + GFP, MnSOD vs 2-DG
+ Mn SOD, UCP2 vs 2-DG + UCP2, p,0.05 GFP vs. MnSOD or UCP2). D: HUVEC were transfected with control siRNA or UCP-2-targeted siRNA for
24 hrs. Then the cells were treated with 5 mM of 2-DG for 10 min. (n=3; two-way ANOVA, *p,0.05, 2-DG vs vehicle, p,0.05 control siRNA vs. UCP2
siRNA). F: Confluent BAEC monolayers were pre-treated with allopurinol (100 mM) or oxypurinol (30 mM) for 30 min and then treated with 5 mM of
2-DG for 10 min.
doi:10.1371/journal.pone.0017234.g007
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sensor that effectively operates in a variety of physiological and
pathological conditions.
Another important finding in this study is that 2-DG-induced
ROS-activated AMPK activation prevents mitochondrial ROS
generation using a feedback system. Our data suggest an intricate
balance between AMPK signaling and the redox state of vascular
endothelial cells. AMPK activation maintains redox homeostasis
by inhibiting intracellular ROS production from mitochondrial,
NAD(P)H oxidase or by increasing anti-oxidant gene expression.
Our group previously reported that AMPK activation up-regulates
UCP-2 expression to prevent oxidant stress [52]. Additional
indirect evidence of these redox regulating properties has been
described. For example, AICAR induces AMPK activation and
attenuates the ROS production seen in hyperglycemia [20].
Rosiglitazone, a thiozolidinedione drug, also induces AMPK
activation and prevents hyperglycemia-induced ROS production
[53]. AMPK activation can also inhibit ROS production from
other sources, such as NAD(P)H oxidase and adiponectin exposure
[54]. Moreover, AMPK has also been implicated in the regulation
of anti-oxidant enzyme expression in endothelial cells by directly
regulating the forkhead box O (FoxO) 1 and 3 transcription factors
[55] to induce expression of thioredoxin (Trx), which is an
important ROS scavenger. Indeed, investigators have also
identified AMPK-FoxO-Trx as being involved in the cellular
antioxidant defense mounted against disparate ROS/cell stress
triggers, such as shear stress [56] and free fatty acid stimulation
[48]. AMPK activation was also reported to increase the
expression of MnSOD [57], and AMPKa1 deletion decreases
the expression of SOD, catalase, c-glutamylcystine synthase, and
Trx [58]. Therefore, AMPK activation appears to be an important
target for maintaining cellular redox homeostasis.
Endothelial dysfunction is one of the earliest events that occurs
in a number of cardiovascular diseases, including atherosclerosis,
hypertension, and diabetes. Endothelia dysfunction is character-
ized by accelerated endothelial cell death [59]. AMPK expression
levels and activation are reduced in the early stages of these
cardiovascular diseases [26,60]. Thus, the defects in the ROS-
AMPK-autophagy pathway described in these studies may
contribute to the initiation and progression of endothelial
dysfunction. Therefore, greater insight into the complex autoph-
agic and apoptotic regulatory controls in the endothelium and
vascular smooth muscle system is likely to lead to improved clinical
treatments for related diseases.
Figure 8. Inhibitory effect of 2-DG-induced autophagy on cell death during hypoxia is dependent on ROS and AMPK. A: BAEC cells
were incubated in the absence 5 mM 2-DG for 24 hrs under normoxia (21% oxygen) or hypoxia (1% oxygen) conditions for 12 hrs. LDH in media was
measured to assess cytotoxicity. (n=4; two-way ANOVA, * p,0.05, normoxia vs hypoxia, p,0.05 vehicle vs. 2-DG treatment). B: BAEC were pretreated
with 3-methyladenine (3-MA) for 0.5 hr and then treated with 5 mM 2-DG for 24 hrs. Then, BAEC were incubated in hypoxic conditions for 12 hrs.
(n=4;*p,0.05, two-way ANOVA, vehicle vs. 2-DG treatment, p,0.05, 2-DG vs. 2-DG + 3-methyladenine). C: BAEC were transduced with adenovirus
vectors encoding SOD1 or catalase for 48 hrs and then treated with 5 mM 2-DG for 24 hrs. Then, BAEC were incubated in hypoxic conditions for
12 hrs. (n=4; two-way ANOVA, *p,0.05, vehicle vs. 2-DG treatment, p,0.05, GFP + 2-DG vs. SOD1 or catalase overexpression + 2-DG). D: BAEC were
transduced with adenovirus vectors encoding AMPK-DN or AMPK-CA for 48 hrs and then treated with 5 mM 2-DG for 24 hrs. Then, BAEC were
incubated in hypoxic conditions for 12 hrs. (n=4; two-way ANOVA, *p,0.05, vehicle vs. 2-DG treatment, p,0.05, GFP vs. AMPK-DN). E: The model for
2-DG-induced autophagy in endothelial cells. 2-DG increased H2O2 production by mitochondria and the AMP:ATP ratio in endothelial cells. H2O2
subsequently increased AMPK activation, independent of a change in the AMP:ATP ratio. ROS-dependent activation of AMPK by 2-DG is required for
autophagy.
doi:10.1371/journal.pone.0017234.g008
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